GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Russian Journal of Transplantology and Artificial Organs, V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs, Vol. 22, No. 3 ( 2020-10-06), p. 8-17
    Abstract: We herein present our initial report from «ROKKOR-recipient», a national multicenter observational study. The prevalence, risk factors, clinical manifestations and outcomes of the novel coronavirus disease 2019 (COVID-19) in solid organ transplant recipients receiving immunosuppressive therapy were investigated. The study enrolled 251 COVID-19 patients (220 kidney recipients, 7 liver recipients, 1 liver-kidney recipient, and 23 heart recipients). The subjects came from 20 regions in Russia. The symptoms, clinical presentation, imaging and lab test results, therapy and outcomes of COVID-19 were described. It was established that solid organ transplant recipients with COVID-19 have a higher risk of developing adverse events. Predictors of adverse events include associated cardiovascular diseases, pulmonary diseases, diabetes, and kidney failure. Symptoms of the disease include dyspnea, rash and catarrhal signs, as well as initial low blood oxygen saturation (SpO 2 〈 92%), leukocytosis (white blood cell count 〉 10 × 10 9 /L), elevated creatinine levels ( 〉 130 μmol/L) and a marked decrease in glomerular filtration rate, requiring hemodialysis. Performing organ transplant surgery in COVID-19 does not increase the risk of adverse events but could save the lives of waitlisted terminally ill patients.
    Type of Medium: Online Resource
    ISSN: 2412-6160 , 1995-1191
    URL: Issue
    Language: Unknown
    Publisher: V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs
    Publication Date: 2020
    detail.hit.zdb_id: 3047337-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs ; 2023
    In:  Russian Journal of Transplantology and Artificial Organs Vol. 25, No. 2 ( 2023-07-15), p. 140-147
    In: Russian Journal of Transplantology and Artificial Organs, V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs, Vol. 25, No. 2 ( 2023-07-15), p. 140-147
    Abstract: Growth hormone (GH) plays a leading role in the regulation of cell and tissue metabolism and growth. Its effects are mediated through the so-called somatomedins, among which the most important is the liver-produced insulinlike growth factor 1 (IGF-1). It has been reported that serum GH levels in liver recipients is related to the clinical transplant outcomes. Objective: to evaluate the prognostic significance of GH in pediatric liver transplantation (LT). Materials and methods . The study enrolled 148 children (61 boys) aged 2 to 60 months (median, 8) with end-stage liver disease resulting from biliary atresia (n = 86), biliary hypoplasia (n = 14), Byler disease (n = 15), Alagille syndrome (n = 12), Caroli syndrome (n = 5), and other liver diseases (n = 16, cryptogenic cirrhosis, fulminant and autoimmune hepatitis, Crigler–Najjar and Budd–Chiari syndromes, alpha-1 antitrypsin deficiency, glycogenosis and hepatoblastoma). All the patients were transplanted with the left lateral segment of the liver from a living related donor. GH concentrations were measured by enzyme immunoassay before, at one month and at one year after transplantation. Results. Median plasma GH levels in children with liver disease were 4.3 [1.6–7.2] ng/mL, significantly higher than in healthy children of the same age at 1.2 [0.3–2.4] ng/mL, p = 0.001, while mean height and body weight were lower than in healthy controls. GH levels decreased significantly after transplantation. At one month and one year later, the levels did not differ from those of healthy children (p = 0.74, p = 0.67, respectively). One month after transplantation, GH concentrations were lower in 1-year survivors than in non-survivors (p = 0.02); the diagnostically significant threshold GH level was 1.8 ng/mL. Prior to LT, plasma GH levels did not differ between 1-year survivors and non-survivors. Children with GH levels below 1.8 ng/mL post-LT were 9 times more likely to survive one year post-transplant than patients with levels above the threshold. Conclusion. GH concentrations in pediatric liver recipients is a positive prognostic indicator of pediatric LT outcomes.
    Type of Medium: Online Resource
    ISSN: 2412-6160 , 1995-1191
    Language: Unknown
    Publisher: V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs
    Publication Date: 2023
    detail.hit.zdb_id: 3047337-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs ; 2020
    In:  Russian Journal of Transplantology and Artificial Organs Vol. 22, No. 2 ( 2020-07-12), p. 86-96
    In: Russian Journal of Transplantology and Artificial Organs, V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs, Vol. 22, No. 2 ( 2020-07-12), p. 86-96
    Abstract: Objective : to evaluate the expression levels of miRNA (miR-27, miR-101, miR-142, miR-339 and miR-424) and its relationship with clinical and laboratory parameters in lung transplant recipients. Materials and methods. The study included 57 lung recipients aged 10 to 74 years (35 ± 15), including six children (9%) – four boys 10, 12, 13 and 17 years and girls 13 and 14 years old – and 51 adult recipients, including 30 men (62.5%). The control group was made up of 14 healthy individuals that were not significantly different by gender and age. Expression levels of the microRNAs studied in blood plasma were determined via quantitative polymerase chain reaction (PCR). Correlations of miRNA expression levels with complete blood count and biochemical blood test indicators were analyzed. Results. Patients with end-stage chronic respiratory failure (potential lung recipients) were found to have significantly higher expression levels of miR-27, miR-101 and miR-339 in plasma than the healthy individuals (p = 0.02, p = 0.03 and p = 0.01, respectively). The expression level of miR-339 correlated with the age of potential lung recipients (p = 0.04). It was a negative correlation (r = –0.46). The expression levels of the other four miRNAs were age independent. The average expression level of miR-424 in lung recipients in the long-term period after lung transplant was higher than in waitlisted patients (p = 0.03). Analysis of the relationship between miRNA expression levels and external respiration function in the long-term post-transplant period showed that miR-142 expression level (r = 0.61; p = 0.04) positively correlates with the Tiffeneau-Pinelli index. This strong correlation, which exceeds 85%, indicates the presence of restrictive lung diseases. A year and more after transplantation, it was found that in the recipients, there were close positive correlations between miR-27, miR-142, miR-424 expression levels and blood leukocyte concentration, as well as between the miR-142 expression level and the sCD40L concentration during this period. Conclusion . A comparative study of the expression level of miRNAs (miR-27, miR-101, miR-142, miR-339 and miR-424) in the blood plasma of patients suffering from end-stage chronic lung diseases of various origin and in lung recipients enables us to conclude that further studies of the miRNA panels are needed in order to assess their effectiveness as potential molecular and genetic markers of post-transplant complications.
    Type of Medium: Online Resource
    ISSN: 2412-6160 , 1995-1191
    URL: Issue
    Language: Unknown
    Publisher: V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs
    Publication Date: 2020
    detail.hit.zdb_id: 3047337-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2010
    In:  Transplantation Journal Vol. 90 ( 2010-07), p. 1071-
    In: Transplantation Journal, Ovid Technologies (Wolters Kluwer Health), Vol. 90 ( 2010-07), p. 1071-
    Type of Medium: Online Resource
    ISSN: 0041-1337
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2010
    detail.hit.zdb_id: 2035395-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Transplantation Journal, Ovid Technologies (Wolters Kluwer Health), Vol. 90 ( 2010-07), p. 853-
    Type of Medium: Online Resource
    ISSN: 0041-1337
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2010
    detail.hit.zdb_id: 2035395-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Annals of Surgical Hepatology ; 2018
    In:  Annaly khirurgicheskoy gepatologii = Annals of HPB surgery Vol. 23, No. 1 ( 2018-04-10), p. 13-18
    In: Annaly khirurgicheskoy gepatologii = Annals of HPB surgery, Annals of Surgical Hepatology, Vol. 23, No. 1 ( 2018-04-10), p. 13-18
    Type of Medium: Online Resource
    ISSN: 2408-9524 , 1995-5464
    Language: Unknown
    Publisher: Annals of Surgical Hepatology
    Publication Date: 2018
    detail.hit.zdb_id: 3102212-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs ; 2021
    In:  Russian Journal of Transplantology and Artificial Organs Vol. 23, No. 2 ( 2021-07-12), p. 13-20
    In: Russian Journal of Transplantology and Artificial Organs, V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs, Vol. 23, No. 2 ( 2021-07-12), p. 13-20
    Abstract:   Introduction . To prevent post-transplant complications associated with unbalanced immunosuppression, objective indicators reflecting the state of the immune system and associated with the immunosuppressant dose are required. In pediatric liver transplantation, an important indicator of hepatocellular function and restoration of anthropometric characteristics is insulin-like growth factor 1 (IGF-1), which exhibits both nonspecific and selective immunomodulator properties. Objective : to assess the correlation between growth hormone and IGF-1 levels and tacrolimus dose and blood concentrations in pediatric liver recipients and to determine the possibility of using the IGF-1 level in selecting the drug dose required to achieve its target concentration in the blood. Materials and methods. We examined 156 children aged from 2 to 105 (median – 8) months with liver cirrhosis of various etiology, who received liver from a living related donor. The concentration of growth hormone and IGF-1 was determined in blood plasma before, one month, and one year after transplantation using the enzyme-linked immunosorbent assay. Tacrolimus residual concentration was measured in the patient’s whole blood by immunochemical method. Results . Growth hormone levels in the blood of pediatric liver recipients did not correlate with the dose or concentration of immunosuppressant tacrolimus one month or one year after transplantation, whereas the IGF-1 content was directly related to tacrolimus dose one year later (r = 0.41, p = 0.001), but not a month after surgery. The correlation coefficient was higher in uncomplicated post-transplant recipients (r = 0.51, p = 0.002) than in those with complications (r = 0.26, p = 0.17). The diagnostic efficiency of the IGF-1 level as an objective criterion for selecting the tacrolimus dose required to achieve its target blood concentration was 0.80 ± 0.11; 95% CI [0.58–1.00] (p = 0.007). In recipients with blood IGF-1 levels ≥115.7 ng/mL, the probability of prescribing a tacrolimus dose ≥0.25 mg/kg/day was 14 times higher than in children with lower blood IGF-1 levels. The estimated accuracy of the test was 83%, positive predictive value was 71%, and negative predictive value was 85%. Conclusion . The IGF-1 level was found to correlate with tacrolimus dose in liver transplant recipients one year after transplantation. The diagnostic efficiency of IGF-1 as a potential indicator for choosing the tacrolimus dose required to achieve its target blood concentration is 80%, which suggests further study of the test to assess the effectiveness of immunosuppression and selection of an individual immunosuppressant dose.
    Type of Medium: Online Resource
    ISSN: 2412-6160 , 1995-1191
    Language: Unknown
    Publisher: V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs
    Publication Date: 2021
    detail.hit.zdb_id: 3047337-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs ; 2014
    In:  Russian Journal of Transplantology and Artificial Organs Vol. 15, No. 2 ( 2014-05-16), p. 56-
    In: Russian Journal of Transplantology and Artificial Organs, V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs, Vol. 15, No. 2 ( 2014-05-16), p. 56-
    Type of Medium: Online Resource
    ISSN: 1995-1191
    URL: Issue
    Language: Unknown
    Publisher: V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs
    Publication Date: 2014
    detail.hit.zdb_id: 3047337-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs ; 2014
    In:  Russian Journal of Transplantology and Artificial Organs Vol. 15, No. 4 ( 2014-05-14), p. 47-
    In: Russian Journal of Transplantology and Artificial Organs, V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs, Vol. 15, No. 4 ( 2014-05-14), p. 47-
    Type of Medium: Online Resource
    ISSN: 1995-1191
    URL: Issue
    Language: Unknown
    Publisher: V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs
    Publication Date: 2014
    detail.hit.zdb_id: 3047337-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs ; 2021
    In:  Russian Journal of Transplantology and Artificial Organs Vol. 23, No. 3 ( 2021-09-16), p. 82-89
    In: Russian Journal of Transplantology and Artificial Organs, V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs, Vol. 23, No. 3 ( 2021-09-16), p. 82-89
    Abstract: Respiratory diseases, together with infectious complications and hereditary lung diseases, rank third in international mortality statistics. Today, lung transplantation is a recognized method of treating end-stage lung diseases. However, the number of transplant surgeries performed is not much. This is down to the high requirements on the condition of a potential lung donor and directly on the quality of the donor lung. This has significantly limited the number of optimal donors. Rehabilitation of donor lungs to optimal gas exchange indicators can be achieved and objectively assessed in the course of ex vivo lung perfusion (EVLP). The EVLP procedure is widespread in leading transplantation centers in Europe and North America. It allows to significantly expand the pool of donor lungs, thereby serving a greater number of patients in need of lung transplantation. The possibility of EVLP procedure using publicly available perfusion equipment was demonstrated. The optimized protocol fully demonstrated its reliability and efficiency. The developed perfusion solution had no statistically significant differences in comparison with the Steen SolutionTM, which in the future will serve as an alternative for EVLP procedure.
    Type of Medium: Online Resource
    ISSN: 2412-6160 , 1995-1191
    Language: Unknown
    Publisher: V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs
    Publication Date: 2021
    detail.hit.zdb_id: 3047337-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...